Get the Stockscreener App
5.94
2.95%
0.17
Evommune Inc Stock (EVMN) Forecast
The Evommune Inc (EVMN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.4924, representing a +9.30% increase from the current price of $5.94. The highest analyst price target is $10.81, and the lowest is $2.1748.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVMN Price Target
Average 12.59
(+111.91% Upside)
Is Evommune Inc (EVMN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 20.61 | Buy |
| STOCH(9,6) | 8.8256 | Buy |
| STOCHRSI(14) | 44.90 | Neutral |
| MACD(12,26) | -1.3815 | Buy |
| ADX(14) | 56.43 | Sell |
| William %R | -90.03 | Buy |
| CCI(14) | -41.65 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.27
Sell
|
6.4389
Sell
|
| MA20 |
7.4835
Sell
|
7.4504
Sell
|
| MA50 |
10.67
Sell
|
9.9417
Sell
|
| MA100 |
13.66
Sell
|
12.90
Sell
|
| MA200 |
18.46
Sell
|
16.82
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EVMN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on EVMN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 20.61 indicates that EVMN is oversold. This indicates that EVMN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 8.8256 indicates that EVMN is oversold. This indicates that EVMN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.9 indicates that EVMN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 56.43 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -41.65 indicates that EVMN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EVMN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evommune Inc financial reports and earnings history, Evommune Inc (EVMN) stock could reach $29.55 by 2030, $100.47 by 2040 and $137.30 by 2050. See the projected annual prices until 2050 of the Evommune Inc stock below:
- Evommune Inc (EVMN) is expected to reach an average price of $39.39 in 2035, with a high prediction of $40.11 and a low estimate of $35.14. This indicates an $563.12% rise from the last recorded price of $5.94.
- Evommune Inc (EVMN) stock is projected to chart a bullish course in 2040, with an average price target of $99.83, representing an $1,581% surge from its current level. The forecast ranges from a conservative $101.37 to a sky-high $100.47.
- Our analysts predict Evommune Inc (EVMN) to jump 3,321% by 2045, soaring from $64.34 to an average price of $203.23, potentially reaching $204.34. While $64.34 is the low estimate, the potential upside is significant.
- Evommune Inc (EVMN) stock is expected to climb by 2050, reaching an average of $131.90, a $2,121% jump from its current level. However, a wide range of estimates exists, with high and low targets of $137.30 and $133.04, respectively, highlighting the market's uncertainty.
Evommune Inc Stock (EVMN) Year by Year Forecast
Evommune Inc Stock (EVMN) Price Forecast for 2026
The predicted value for Evommune Inc (EVMN) in 2026 is set at an average of $17.69. Estimates vary from a peak of $33.20 to a trough of $2.1748, indicating an +197.77% surge from the present price of $5.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $6.5398 | $2.1748 | $10.81 | +10.10% |
| December, 2026 | $9.0397 | $3.6797 | $9.6697 | +52.18% |
Evommune Inc Stock (EVMN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evommune Inc (EVMN) is $12.26, with a high forecast of $23.00 and a low forecast of $1.5234. This indicates an +106.42% increase from the last price of $5.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.8396 | $5.4236 | $12.70 | +15.14% |
| February, 2027 | $16.65 | $5.6546 | $23.00 | +180.29% |
| March, 2027 | $14.64 | $11.24 | $17.13 | +146.54% |
| April, 2027 | $15.34 | $14.64 | $20.46 | +158.32% |
| May, 2027 | $15.55 | $13.19 | $17.19 | +161.77% |
| June, 2027 | $18.12 | $11.90 | $18.81 | +205.03% |
| July, 2027 | $5.6989 | $5.0589 | $11.39 | -4.06% |
| August, 2027 | $8.3537 | $4.1838 | $9.3937 | +40.64% |
| September, 2027 | $5.4936 | $5.2537 | $8.9305 | -7.51% |
| October, 2027 | $2.4935 | $2.3135 | $5.7345 | -58.02% |
| November, 2027 | $5.9501 | $1.5234 | $4.5801 | +0.17% |
| December, 2027 | $5.1703 | $3.5302 | $4.0203 | -12.96% |
Evommune Inc Stock (EVMN) Price Forecast for 2028
In 2028, Evommune Inc (EVMN) is projected to reach an average price of $8.6362, with a high projection of $17.07 and a low estimate of $0.2073. This indicates an +45.39% rise from the last price of $5.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.0706 | $5.4905 | $4.7104 | -14.64% |
| February, 2028 | $10.94 | $3.5807 | $12.57 | +84.16% |
| March, 2028 | $2.5989 | $1.5439 | $12.84 | -56.25% |
| April, 2028 | $5.5687 | $1.8688 | $6.8487 | -6.25% |
| May, 2028 | $7.8984 | $5.8886 | $11.85 | +32.97% |
| June, 2028 | $7.8682 | $5.3582 | $8.9684 | +32.46% |
| July, 2028 | $0.5221 | $0.6321 | $11.75 | -91.21% |
| August, 2028 | $1.2123 | $0.9922 | $0.9178 | -79.59% |
| September, 2028 | $2.6875 | $1.0524 | $3.7275 | -54.76% |
| October, 2028 | $0.1328 | $0.2073 | $3.4192 | -97.76% |
| November, 2028 | $2.2931 | $1.0529 | $1.3267 | -61.40% |
| December, 2028 | $18.28 | $2.5931 | $17.07 | +207.75% |
Evommune Inc Stock (EVMN) Price Forecast for 2029
The 2029 price forecast for Evommune Inc Stock (EVMN) is $8.2157 on average, with a high prediction of $16.27 and a low estimate of $0.1658. This represents an +38.31% increase from the previous price of $5.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $17.46 | $15.55 | $16.27 | +193.87% |
| February, 2029 | $16.01 | $16.45 | $15.95 | +169.46% |
| March, 2029 | $0.6237 | $14.21 | $12.80 | -89.50% |
| April, 2029 | $5.2917 | $3.9814 | $3.1218 | -10.91% |
| May, 2029 | $1.252 | $3.032 | $3.8384 | -78.92% |
| June, 2029 | $0.4024 | $0.6922 | $3.2378 | -93.23% |
| July, 2029 | $2.6578 | $0.6127 | $1.1173 | -55.26% |
| August, 2029 | $7.4281 | $0.1658 | $4.6869 | +25.05% |
| September, 2029 | $7.4985 | $7.7183 | $6.4885 | +26.24% |
| October, 2029 | $3.3039 | $3.5639 | $6.3836 | -44.38% |
| November, 2029 | $5.0242 | $3.459 | $4.0483 | -15.42% |
| December, 2029 | $6.5797 | $5.6344 | $6.1297 | +10.77% |
Evommune Inc Stock (EVMN) Price Forecast for 2030
Evommune Inc Stock (EVMN) is expected to reach an average price of $18.22 in 2030, with a high forecast of $29.55 and a low forecast of $6.8952. This signifies an +206.78% surge from the last price of $5.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.99 | $30.26 | $29.55 | +371.22% |
| February, 2030 | $29.01 | $27.57 | $27.82 | +388.40% |
| March, 2030 | $26.94 | $27.38 | $27.19 | +353.56% |
| April, 2030 | $12.33 | $14.14 | $23.58 | +107.61% |
| May, 2030 | $14.83 | $15.02 | $12.66 | +149.70% |
| June, 2030 | $10.17 | $11.95 | $13.07 | +71.26% |
| July, 2030 | $9.6633 | $9.3029 | $7.7132 | +62.68% |
| August, 2030 | $10.18 | $8.2936 | $7.3335 | +71.44% |
| September, 2030 | $14.04 | $6.8952 | $13.10 | +136.44% |
| October, 2030 | $13.29 | $13.72 | $12.77 | +123.82% |
| November, 2030 | $8.8152 | $9.0752 | $9.5449 | +48.40% |
| December, 2030 | $10.46 | $8.8153 | $9.0808 | +76.02% |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):